NPCE Neuropace, Inc. - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 11, 2026
$12,70
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$9,2252-Wochen-Tief
$19,6052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$435M
P/E (TTM)
-22.3
EPS (TTM)
$-0.57
Umsatz (TTM)
$99M
Ihre Abzeichen
52W-Spanne
$9–$20
Analystenbewertung
BUY
Kursziel
$20
P/E
-22.3
ROE
-122.1%
Nettogewinnmarge
-19.3%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
NPCE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$12.70
Marktkapitalisierung (MRQ)
$435M
P/E (TTM)
-22.3
EPS (TTM)
$-0.57
Umsatz (TTM)
$99M
ROE (TTM)
-122.1%
Verschuldungsgrad (MRQ)
5.0
52W-Spanne
$9–$20
NPCE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Neuropace, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealth Care
BrancheHealth Care
Mitarbeiter220
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$100M2020-12-31 → 2025-12-31
EPS$-0.662020-12-31 → 2025-12-31
Freier Cashflow$-11M2021-12-31 → 2025-12-31
Nettogewinnmarge-19.3%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | NPCE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -22.35-Jahres-Durchschnitt ≈-9.8 | ≈-9.8 | · | · | |
| P/S (TTM) | 4.45-Jahres-Durchschnitt ≈4.0 | ≈4.0 | 4.2 | Überbewertet | |
| K/B (MRQ) | 36.65-Jahres-Durchschnitt ≈17.5 | ≈17.5 | 3.5 | Überbewertet | |
| EV / EBITDA | -26.25-Jahres-Durchschnitt ≈-13.1 | ≈-13.1 | · | · | |
| Kurs / FCF (TTM) | -37.55-Jahres-Durchschnitt ≈-17.9 | ≈-17.9 | · | · | |
| Kurs / Cashflow (TTM) | -38.75-Jahres-Durchschnitt ≈-18.3 | ≈-18.3 | · | · | |
| EV / Umsatz (TTM) | 4.55-Jahres-Durchschnitt ≈3.6 | ≈3.6 | · | · | |
| EV / FCF (TTM) | -38.15-Jahres-Durchschnitt ≈-17.2 | ≈-17.2 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 22.65-Jahres-Durchschnitt ≈17.5 | ≈17.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | NPCE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 79.6%5-Jahres-Durchschnitt ≈74.0% | ≈74.0% | 76.2% | Spitzenklasse | |
| Betriebsgewinnmarge (TTM) | -15.3%5-Jahres-Durchschnitt ≈-45.4% | ≈-45.4% | -14.5% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -16.3%5-Jahres-Durchschnitt ≈-45.4% | ≈-45.4% | -14.5% | Schwach | |
| Nettogewinnmarge (TTM) | -19.3%5-Jahres-Durchschnitt ≈-57.8% | ≈-57.8% | -15.2% | Schwach | |
| ROA (TTM) | -18.8%5-Jahres-Durchschnitt ≈-30.8% | ≈-30.8% | -17.4% | Unterdurchschnittlich | |
| ROE (TTM) | -122.1%5-Jahres-Durchschnitt ≈-152.2% | ≈-152.2% | -39.3% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | NPCE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 5.05-Jahres-Durchschnitt ≈3.1 | ≈3.1 | 0.7 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 4.95-Jahres-Durchschnitt ≈7.9 | ≈7.9 | 4.8 | Im Einklang | |
| Quick Ratio (MRQ) | 3.85-Jahres-Durchschnitt ≈6.9 | ≈6.9 | 3.7 | Im Einklang | |
| Langfristige Schulden / Eigenkapital (MRQ) | 5.05-Jahres-Durchschnitt ≈3.1 | ≈3.1 | 0.6 | Hohe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | NPCE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 25.1%5-Jahres-Durchschnitt ≈20.3% | ≈20.3% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 30.0%5-Jahres-Durchschnitt ≈22.5% | ≈22.5% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 19.4% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | NPCE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 1.05-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.7 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 1.55-Jahres-Durchschnitt ≈1.6 | ≈1.6 | 2.3 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 7.35-Jahres-Durchschnitt ≈6.5 | ≈6.5 | 7.0 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$454.5K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
20.1%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-0.18 | $-0.21 | 14.6% |
| 31. März 2026 | Mai 11, 2026 | $-0.20 | $-0.23 | 12.4% |
| 31. Dezember 2025 | $-0.08 | $-0.15 | 48.2% | |
| 30. September 2025 | $-0.11 | $-0.20 | 45.1% | |
| 30. Juni 2025 | $-0.26 | $-0.23 | -14.5% | |
| 31. März 2025 | $-0.21 | $-0.25 | 14.7% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $100M | $80M | $65M | $46M | $45M | $41M | |
| Cost of Revenue | $23M | $21M | $17M | $13M | $12M | $11M | |
| Gross Profit | $77M | $59M | $48M | $32M | $33M | $30M | |
| R&D Expense | $28M | $24M | $21M | $22M | $18M | $16M | |
| SG&A Expense | $19M | $17M | $55M | $51M | $39M | $28M | |
| Operating Expenses | $94M | $81M | $75M | $73M | $57M | $43M | |
| Operating Income | $-16M | $-22M | $-27M | $-41M | $-24M | $-13M | |
| Interest Expense | · | · | $9M | $8M | $7M | $11M | |
| Interest Income | $3M | $3M | $3M | $2M | $448.0K | $41.0K | |
| Other Non-op | $-486.0K | $304.0K | $-315.0K | $-337.0K | $-5M | $218.0K | |
| Income Tax | $0 | · | · | · | · | · | |
| Net Income | $-21M | $-27M | $-33M | $-47M | $-36M | $-24M | |
| EPS (Basic) | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 | $-117.85 | |
| EPS (Diluted) | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 | $-117.85 | |
| Shares (Basic) | 32,722,438 | 29,126,314 | 25,851,813 | 24,594,784 | 16,608,800 | 204,068 | |
| Shares (Diluted) | 32,722,438 | 29,126,314 | 25,851,813 | 24,594,784 | 16,608,800 | 204,068 | |
| EBITDA | $-16M | $-22M | $-27M | $-41M | $-24M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22M | $13M | $18M | $7M | $19M | $26M | |
| Short-term Investments | $39M | $39M | $48M | $71M | $96M | $12M | |
| Receivables | $13M | $13M | $12M | $7M | $7M | $8M | |
| Inventory | $15M | $13M | $11M | $10M | $8M | $7M | |
| Prepaid Expense | $1M | $2M | $3M | $3M | $2M | $1M | |
| Current Assets | $94M | $81M | $93M | $98M | $133M | $55M | |
| PP&E (Net) | $1M | $1M | $1M | $1M | $603.0K | $515.0K | |
| PP&E (Gross) | $9M | $9M | $9M | $10M | $9M | $9M | |
| Accum. Depreciation | $8M | $8M | $8M | $9M | $8M | $8M | |
| Other Non-current Assets | $113.0K | $15.0K | $15.0K | $21.0K | $21.0K | $23.0K | |
| Total Assets | $106M | $95M | $108M | $114M | $134M | $56M | |
| Accounts Payable | $2M | $3M | $2M | $2M | $1M | $949.0K | |
| Accrued Liabilities | $13M | $10M | $11M | $7M | $8M | $7M | |
| Current Liabilities | $18M | $15M | $16M | $11M | $9M | $10M | |
| Capital Leases | $10M | $12M | $14M | $15M | $0 | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $274.0K | |
| Total Liabilities | $87M | $87M | $87M | $79M | $60M | $62M | |
| Long-term Debt | · | · | · | · | $50M | $53M | |
| Total Debt | $59M | $60M | $57M | $53M | $50M | · | |
| Common Stock | $34.0K | $30.0K | $28.0K | $25.0K | $24.0K | $0 | |
| Paid-in Capital | $571M | $539M | $524M | $507M | $498M | $240M | |
| Retained Earnings | $-552M | $-531M | $-504M | $-471M | $-424M | $-388M | |
| AOCI | · | · | $0 | $-1M | $-272.0K | $33.0K | |
| Stockholders' Equity | $19M | $8M | $21M | $35M | $74M | $-148M | |
| Liabilities + Equity | $106M | $95M | $108M | $114M | $134M | $56M | |
| Shares Outstanding | 33,574,759 | 30,145,039 | 27,823,465 | 25,045,751 | 24,452,999 | 314,096 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $10M | $10M | $8M | $4M | $1M | |
| Operating Cash Flow | $-11M | $-18M | $-20M | $-37M | $-25M | $-22M | |
| CapEx | $332.0K | $306.0K | $173.0K | $603.0K | $384.0K | $62.0K | |
| Investing Cash Flow | $-332.0K | $9M | $23M | $24M | $-85M | $-11M | |
| Stock Repurchased | $50M | $0 | · | · | · | · | |
| Net Stock Activity | $-50M | · | · | · | · | · | |
| Financing Cash Flow | $20M | $4M | $8M | $490.0K | $103M | $55M | |
| Net Change in Cash | $8M | $-5M | $11M | $-13M | $-7M | $23M | |
| Free Cash Flow | $-11M | $-18M | $-20M | $-37M | $-25M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 77.2% | 73.9% | 73.6% | 71.4% | 74.0% | · | |
| Operating Margin | -16.3% | -27.1% | -41.5% | -89.6% | -52.5% | · | |
| Net Margin | -21.5% | -34.0% | -50.4% | -103.4% | -79.8% | · | |
| EBITDA Margin | -16.3% | -27.1% | -41.5% | -89.6% | -52.5% | · | |
| ROA | -21.4% | -26.8% | -29.7% | -38.0% | -38.1% | · | |
| ROE | -111.6% | -304.3% | -178.1% | -120.4% | -46.5% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.3 | 5.4 | 5.7 | 8.9 | 14.3 | · | |
| Quick Ratio | 4.3 | 4.3 | 4.9 | 7.7 | 13.2 | · | |
| Debt / Equity | 3.1 | 7.4 | 2.8 | 1.5 | 0.7 | · | |
| LT Debt / Equity | 3.1 | 7.4 | 2.8 | 1.5 | 0.7 | · | |
| Interest Coverage | · | · | -3.2 | -5.4 | -3.2 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.8 | 0.6 | 0.4 | 0.5 | · | |
| Inventory Turnover | 1.5 | 1.7 | 1.7 | 1.5 | 1.6 | · | |
| Receivables Turnover | 7.3 | 6.4 | 6.6 | 6.2 | 5.8 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.57 | $0.27 | $0.74 | $1.39 | $3.01 | · | |
| Revenue / Share | $3.06 | $2.74 | $2.53 | $1.85 | $2.72 | · | |
| Cash Flow / Share | $-0.34 | $-0.62 | $-0.76 | $-1.50 | $-1.48 | · | |
| Cash / Share | $0.65 | $0.45 | $0.65 | $0.26 | $0.78 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | · | · | · | |
| EPS (TTM) | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 25.1% | 22.1% | 43.7% | 0.75% | 9.8% | · | |
| Revenue CAGR 3Y | 30.0% | 20.9% | 16.7% | · | · | · | |
| Revenue CAGR 5Y | 19.4% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $100M | $80M | $65M | $46M | $45M | · | |
| Net Income TTM | $-21M | $-27M | $-33M | $-47M | $-36M | · | |
| Market Cap | $518M | $337M | $287M | $37M | $246M | · | |
| Enterprise Value | $516M | $344M | $277M | $13M | $181M | · | |
| P/E | -23.4 | -12.0 | -8.1 | -0.8 | -4.6 | · | |
| P/S | 5.2 | 4.2 | 4.4 | 0.8 | 5.5 | · | |
| P/B | 27.2 | 42.1 | 13.9 | 1.1 | 3.4 | · | |
| P / Tangible Book | 27.2 | 42.1 | 13.9 | 1.1 | 3.4 | · | |
| P / Cash Flow | -47.1 | -18.8 | -14.6 | -1.0 | -10.0 | · | |
| P / FCF | -45.7 | -18.5 | -14.4 | -1.0 | -9.9 | · | |
| EV / EBITDA | -31.6 | -15.9 | -10.2 | -0.3 | -7.6 | · | |
| EV / FCF | -45.5 | -18.8 | -14.0 | -0.3 | -7.2 | · | |
| EV / Revenue | 5.2 | 4.3 | 4.2 | 0.3 | 4.0 | · | |
| Earnings Yield | -4.3% | -8.3% | -12.3% | -128.2% | -21.5% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23M | $22M | $27M | $27M | $20M | $23M | $21M | $21M | $19M | $18M | $18M | $16M | $17M | $14M | $13M | $11M | |
| Cost of Revenue | $4M | $4M | $6M | $6M | $3M | $5M | $5M | $6M | $5M | $5M | $4M | $4M | $5M | $4M | $4M | $3M | |
| Gross Profit | $19M | $18M | $21M | $21M | $16M | $17M | $16M | $15M | $14M | $13M | $14M | $12M | $12M | $10M | $9M | $8M | |
| R&D Expense | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $6M | |
| SG&A Expense | $5M | $5M | $-7M | $5M | $6M | $4M | $-6M | $4M | $5M | $15M | $13M | $13M | $14M | $13M | $14M | $13M | |
| Operating Expenses | $24M | $24M | $22M | $24M | $24M | $22M | $20M | $20M | $20M | $21M | $19M | $18M | $20M | $19M | $19M | $18M | |
| Operating Income | $-5M | $-6M | $-2M | $-3M | $-8M | $-5M | $-4M | $-4M | $-6M | $-8M | $-5M | $-6M | $-8M | $-8M | $-10M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $2M | $2M | $2M | $2M | $2M | |
| Interest Income | $523.0K | $565.0K | $638.0K | $667.0K | $718.0K | $793.0K | $681.0K | $754.0K | $762.0K | $827.0K | $822.0K | $769.0K | $733.0K | $726.0K | $800.0K | $423.0K | |
| Other Non-op | $-41.0K | $-165.0K | $0 | $82.0K | $-486.0K | $-82.0K | $-86.0K | $219.0K | $120.0K | $51.0K | $265.0K | $115.0K | $122.0K | $-817.0K | $-146.0K | $-103.0K | |
| Income Tax | · | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income | $-6M | $-7M | $-3M | $-3M | $-9M | $-7M | $-5M | $-5M | $-8M | $-9M | $-6M | $-7M | $-9M | $-10M | $-11M | $-12M | |
| EPS (Basic) | $-0.18 | $-0.20 | $-0.08 | $-0.11 | $-0.26 | $-0.21 | $-0.16 | $-0.19 | $-0.26 | $-0.32 | $-0.22 | $-0.28 | $-0.36 | $-0.41 | $-0.44 | $-0.48 | |
| EPS (Diluted) | $-0.18 | $-0.20 | $-0.08 | $-0.11 | $-0.26 | $-0.21 | $-0.16 | $-0.19 | $-0.26 | $-0.32 | $-0.22 | $-0.28 | $-0.36 | $-0.41 | $-0.44 | $-0.48 | |
| Shares (Basic) | 34,104,430 | 33,716,813 | · | 33,134,606 | 32,863,031 | 31,480,911 | · | 29,444,625 | 28,853,216 | 28,285,176 | · | 26,017,329 | 25,472,526 | 25,097,262 | · | 24,728,701 | |
| Shares (Diluted) | 34,104,430 | 33,716,813 | · | 33,134,606 | 32,863,031 | 31,480,911 | · | 29,444,625 | 28,853,216 | 28,285,176 | · | 26,017,329 | 25,472,526 | 25,097,262 | · | 24,728,701 | |
| EBITDA | $-5M | $-6M | · | $-3M | $-7M | $-5M | · | $-4M | $-6M | $-8M | · | $-6M | $-8M | $-8M | · | $-10M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $15M | $22M | $21M | $23M | $27M | $13M | $15M | $13M | $13M | $18M | $10M | $8M | $7M | $7M | $6M | |
| Short-term Investments | $39M | $39M | $39M | $39M | $39M | $39M | $39M | $41M | $43M | $46M | $48M | $52M | $56M | $61M | $71M | · | |
| Receivables | $15M | $15M | $15M | $15M | $14M | $15M | $13M | $12M | $11M | $12M | $12M | $11M | $11M | $9M | $7M | $8M | |
| Inventory | $18M | $17M | $17M | $18M | $16M | $14M | $13M | $12M | $11M | $11M | $11M | $10M | $10M | $11M | $10M | $9M | |
| Prepaid Expense | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | |
| Current Assets | $86M | $87M | $94M | $95M | $94M | $97M | $81M | $83M | $80M | $84M | $93M | $84M | $87M | $90M | $98M | $104M | |
| PP&E (Net) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $998.0K | $1M | $1M | $949.0K | $976.0K | $1M | $1M | $894.0K | |
| PP&E (Gross) | $10M | $10M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | |
| Accum. Depreciation | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | |
| Other Non-current Assets | $98.0K | $106.0K | $113.0K | $120.0K | $87.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $21.0K | $21.0K | $21.0K | $21.0K | |
| Total Assets | $97M | $99M | $106M | $107M | $106M | $110M | $95M | $96M | $94M | $99M | $108M | $99M | $102M | $106M | $114M | $120M | |
| Accounts Payable | $4M | $5M | $2M | $5M | $5M | $4M | $3M | $2M | $2M | $3M | $2M | $1M | $2M | $2M | $2M | $1M | |
| Accrued Liabilities | $11M | $9M | $13M | $12M | $10M | $8M | $10M | $10M | $8M | $7M | $11M | $10M | $8M | $7M | $7M | $8M | |
| Current Liabilities | $17M | $16M | $18M | $20M | $17M | $15M | $15M | $15M | $13M | $13M | $16M | $13M | $12M | $10M | $11M | $9M | |
| Capital Leases | $9M | $9M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | $13M | $14M | $14M | $15M | $15M | $15M | $16M | |
| Total Liabilities | $85M | $84M | $87M | $89M | $87M | $86M | $87M | $86M | $85M | $85M | $87M | $83M | $81M | $79M | $79M | $77M | |
| Total Debt | $59M | $59M | · | $59M | $59M | $60M | · | $59M | $59M | $58M | · | $56M | $55M | $54M | · | $52M | |
| Common Stock | $34.0K | $34.0K | $34.0K | $33.0K | $33.0K | $33.0K | $30.0K | $30.0K | $29.0K | $29.0K | $28.0K | $26.0K | $26.0K | $25.0K | $25.0K | $25.0K | |
| Paid-in Capital | $577M | $574M | $571M | $568M | $566M | $562M | $539M | $535M | $530M | $527M | $524M | $514M | $512M | $509M | $507M | $504M | |
| Retained Earnings | $-565M | $-559M | $-552M | $-550M | $-546M | $-538M | $-531M | $-526M | $-520M | $-513M | $-504M | $-498M | $-490M | $-481M | $-471M | $-460M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-1M | $-1M | |
| Stockholders' Equity | $12M | $14M | $19M | $19M | $19M | $24M | $8M | $10M | $10M | $14M | $21M | $16M | $21M | $27M | $35M | $43M | |
| Liabilities + Equity | $97M | $99M | $106M | $107M | $106M | $110M | $95M | $96M | $94M | $99M | $108M | $99M | $102M | $106M | $114M | $120M | |
| Shares Outstanding | 34,282,567 | 33,909,408 | 33,574,759 | 33,280,887 | 33,044,371 | 32,751,240 | 30,145,039 | 29,777,966 | 29,139,206 | 28,717,452 | 27,823,465 | 26,244,935 | 25,816,929 | 25,352,204 | 25,045,751 | 24,864,119 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | |
| Operating Cash Flow | $-4M | $-6M | $506.0K | $-2M | $-2M | $-7M | $-5M | $-2M | $-4M | $-8M | $-3M | $-2M | $-4M | $-10M | $-8M | $-7M | |
| CapEx | $125.0K | $117.0K | $97.0K | $30.0K | $168.0K | $37.0K | $39.0K | $100.0K | $63.0K | $104.0K | $32.0K | $9.0K | $0 | $132.0K | $102.0K | $31.0K | |
| Investing Cash Flow | $-125.0K | $-117.0K | $-97.0K | $-30.0K | $-168.0K | $-37.0K | $2M | $1M | $3M | $2M | $3M | $4M | $5M | $10M | $9M | $7M | |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $50M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-50M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $1M | $-166.0K | $635.0K | $-235.0K | $-2M | $21M | $848.0K | $3M | $509.0K | $72.0K | $8M | $-27.0K | $195.0K | $-255.0K | $-138.0K | $-8.0K | |
| Net Change in Cash | $-3M | $-6M | $1M | $-2M | $-4M | $14M | $-2M | $3M | $-154.0K | $-5M | $8M | $2M | $1M | $115.0K | $917.0K | $-14.0K | |
| Free Cash Flow | · | $-6M | · | · | · | $-8M | · | · | · | $-8M | · | · | · | $-10M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 82.8% | 81.8% | · | 77.4% | 77.1% | 77.0% | · | 73.2% | 73.4% | 73.6% | · | 74.5% | 72.5% | 71.7% | · | 71.4% | |
| Operating Margin | -22.5% | -25.2% | · | -9.5% | -29.0% | -22.9% | · | -20.2% | -32.4% | -41.6% | · | -36.2% | -47.6% | -57.5% | · | -91.4% | |
| Net Margin | -27.2% | -30.3% | · | -12.8% | -36.8% | -29.2% | · | -25.9% | -39.0% | -49.2% | · | -44.2% | -55.3% | -71.7% | · | -105.6% | |
| EBITDA Margin | -22.5% | -25.2% | · | -9.5% | -29.0% | -22.9% | · | -20.2% | -32.4% | -41.6% | · | -36.2% | -47.6% | -57.5% | · | -91.4% | |
| ROA | -6.1% | -6.4% | · | -3.4% | -8.6% | -6.3% | · | -5.6% | -7.6% | -8.7% | · | -6.6% | -8.3% | -8.8% | · | -9.0% | |
| ROE | -39.6% | -34.5% | · | -24.7% | -59.0% | -34.1% | · | -41.6% | -48.3% | -42.7% | · | -24.3% | -24.6% | -23.0% | · | -18.8% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.4 | · | 4.9 | 5.5 | 6.6 | · | 5.6 | 6.4 | 6.4 | · | 6.6 | 7.5 | 9.1 | · | 11.1 | |
| Quick Ratio | 3.8 | 4.3 | · | 3.8 | 4.4 | 5.6 | · | 4.6 | 5.3 | 5.4 | · | 5.7 | 6.5 | 7.8 | · | 1.4 | |
| Debt / Equity | 5.0 | 4.1 | · | 3.2 | 3.0 | 2.5 | · | 6.0 | 6.0 | 4.0 | · | 3.4 | 2.6 | 2.0 | · | 1.2 | |
| LT Debt / Equity | 5.0 | 4.1 | · | 3.2 | 3.0 | 2.5 | · | 6.0 | 6.0 | 4.0 | · | 3.4 | 2.6 | 2.0 | · | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -3.3 | · | -2.7 | -3.7 | -4.2 | · | -5.4 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.2 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.6 | 1.5 | · | 2.1 | 1.9 | 1.7 | · | 1.8 | 1.7 | 1.7 | · | 1.7 | 1.7 | 1.6 | · | 1.5 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.35 | $0.43 | · | $0.56 | $0.59 | $0.74 | · | $0.33 | $0.34 | $0.50 | · | $0.62 | $0.82 | $1.08 | · | $1.75 | |
| Revenue / Share | $0.67 | $0.65 | · | $0.83 | $0.72 | $0.72 | · | $0.72 | $0.67 | $0.64 | · | $0.63 | $0.65 | $0.58 | · | $0.45 | |
| Cash Flow / Share | · | $-0.17 | · | · | · | $-0.24 | · | · | · | $-0.27 | · | · | · | $-0.39 | · | · | |
| Cash / Share | $0.37 | $0.44 | · | $0.62 | $0.69 | $0.82 | · | $0.52 | $0.44 | $0.45 | · | $0.37 | $0.30 | $0.27 | · | $0.23 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $-0.57 | $-0.65 | · | $-0.74 | $-0.82 | $-0.82 | · | $-0.99 | $-1.08 | $-1.18 | · | $-1.49 | $-1.69 | $-1.85 | · | $29.91 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $99M | $96M | · | $91M | $85M | $84M | · | $76M | $72M | $69M | · | $60M | $55M | $49M | · | $44M | |
| Net Income TTM | $-19M | $-22M | · | $-24M | $-26M | $-25M | · | $-28M | $-30M | $-32M | · | $-38M | $-42M | $-46M | · | $-47M | |
| Market Cap | $545M | $446M | · | $343M | $368M | $403M | · | $208M | $220M | $379M | · | $255M | $116M | $118M | · | $93M | |
| Enterprise Value | $552M | $451M | · | $342M | $365M | $396M | · | $210M | $224M | $378M | · | $250M | $107M | $104M | · | $140M | |
| P/E | -27.9 | -20.2 | · | -13.9 | -13.6 | -15.0 | · | -7.0 | -7.0 | -11.2 | · | -6.5 | -2.7 | -2.5 | · | 0.1 | |
| P/S | 5.5 | 4.7 | · | 3.8 | 4.4 | 4.8 | · | 2.7 | 3.1 | 5.5 | · | 4.2 | 2.1 | 2.4 | · | 2.1 | |
| P/B | 45.8 | 30.9 | · | 18.5 | 18.9 | 16.6 | · | 21.1 | 22.3 | 26.4 | · | 15.6 | 5.5 | 4.3 | · | 2.1 | |
| P / Tangible Book | 45.8 | 30.9 | · | 18.5 | 18.9 | 16.6 | · | 21.1 | 22.3 | 26.4 | · | 15.6 | 5.5 | 4.3 | · | 2.1 | |
| P / Cash Flow | · | -75.6 | · | · | · | -53.8 | · | · | · | -50.4 | · | · | · | -12.1 | · | · | |
| EV / Revenue | 5.6 | 4.7 | · | 3.8 | 4.3 | 4.7 | · | 2.7 | 3.1 | 5.5 | · | 4.2 | 2.0 | 2.1 | · | 3.2 | |
| Earnings Yield | -3.6% | -4.9% | · | -7.2% | -7.4% | -6.7% | · | -14.2% | -14.3% | -8.9% | · | -15.3% | -37.6% | -39.9% | · | 797.6% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $100M | $80M | $65M | $46M | $45M |
| Bruttogewinnmarge % | 77.2% | 73.9% | 73.6% | 71.4% | 74.0% |
| Betriebsgewinnmarge % | -16.3% | -27.1% | -41.5% | -89.6% | -52.5% |
| Nettoergebnis | $-21M | $-27M | $-33M | $-47M | $-36M |
| Verwässerte EPS | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 3.1 | 7.4 | 2.8 | 1.5 | 0.7 |
| Liquiditätsgrad | 5.3 | 5.4 | 5.7 | 8.9 | 14.3 |
| Quick Ratio | 4.3 | 4.3 | 4.9 | 7.7 | 13.2 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-11M | $-18M | $-20M | $-37M | $-25M |
Institutionelle Eigentümer (13F) 118 Einreicher · $464.2M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
118
Gehaltener Wert
$464.2M
Neue Positionen
19
Geschlossene Positionen
18
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 19 (-10 vs. Vorquartal) | 18 (+8 vs. Vorquartal) | 47 (+9 vs. Vorquartal) | 35 (0 vs. Vorquartal) | +120K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Polar Capital Holdings Plc | $52.406.873 | 3.298.104 | 11,29% | Aktien |
| Soleus Capital Management, L.P. | $46.257.729 | 2.911.122 | 9,96% | Aktien |
| First Light Asset Management, LLC | $45.463.944 | 2.861.167 | 9,79% | Aktien |
| MORGAN STANLEY | $42.178.273 | 2.654.391 | 9,09% | Aktien |
| BlackRock, Inc. | $39.369.112 | 2.477.603 | 8,48% | Aktien |
| ORBIMED ADVISORS LLC | $23.916.436 | 1.505.125 | 5,15% | Aktien |
| Driehaus Capital Management LLC | $22.999.043 | 1.447.391 | 4,95% | Aktien |
| VANGUARD GROUP INC | $22.885.600 | 1.482.228 | 4,93% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $19.498.174 | 1.227.072 | 4,20% | Aktien |
| DEUTSCHE BANK AG\ | $14.919.423 | 938.919 | 3,21% | Aktien |
| ARMISTICE CAPITAL, LLC | $10.995.880 | 692.000 | 2,37% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $10.589.998 | 666.300 | 2,28% | Aktien |
| Kent Lake PR LLC | $10.310.000 | 1.000.000 | 2,22% | Aktien |
| KOTLER KEVIN | $9.749.866 | 631.468 | 2,10% | Aktien |
| FMR LLC | $8.815.311 | 554.771 | 1,90% | Aktien |
| STATE STREET CORP | $8.741.597 | 550.132 | 1,88% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5.468.130 | 344.124 | 1,18% | Aktien |
| NORTHERN TRUST CORP | $4.131.798 | 260.025 | 0,89% | Aktien |
| Qube Research & Technologies Ltd | $3.515.456 | 221.237 | 0,76% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.501.695 | 220.371 | 0,75% | Aktien |
| Palumbo Wealth Management LLC | $3.324.173 | 209.199 | 0,72% | Aktien |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $3.316.291 | 208.703 | 0,71% | Aktien |
| ALGERT GLOBAL LLC | $2.936.059 | 184.774 | 0,63% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.900.465 | 182.534 | 0,62% | Aktien |
| JPMORGAN CHASE & CO | $2.864.831 | 173.311 | 0,62% | Aktien |
| HighMark Wealth Management LLC | $2.590.070 | 163.000 | 0,56% | Aktien |
| Russell Investments Group, Ltd. | $2.576.783 | 162.164 | 0,56% | Aktien |
| D. E. Shaw & Co., Inc. | $2.559.577 | 161.081 | 0,55% | Aktien |
| GOLDMAN SACHS GROUP INC | $2.376.604 | 149.566 | 0,51% | Aktien |
| CITADEL ADVISORS LLC | $2.046.632 | 128.800 | 0,44% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $2.029.598 | 127.728 | 0,44% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $1.812.398 | 114.059 | 0,39% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.774.897 | 111.699 | 0,38% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $1.745.898 | 109.874 | 0,38% | Aktien |
| Nuveen, LLC | $1.581.023 | 99.498 | 0,34% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $1.506.372 | 94.800 | 0,32% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.393.188 | 87.677 | 0,30% | Aktien |
| Man Group plc | $1.335.920 | 84.073 | 0,29% | Aktien |
| NORGES BANK | $1.269.611 | 79.900 | 0,27% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.236.735 | 77.831 | 0,27% | Aktien |
| Legato Capital Management LLC | $1.117.607 | 70.334 | 0,24% | Aktien |
| SEI INVESTMENTS CO | $987.993 | 62.177 | 0,21% | Aktien |
| Bank of New York Mellon Corp | $921.255 | 57.977 | 0,20% | Aktien |
| TWO SIGMA ADVISERS, LP | $788.984 | 51.100 | 0,17% | Aktien |
| Informed Momentum Co LLC | $630.134 | 39.656 | 0,14% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $570.769 | 35.920 | 0,12% | Aktien |
| JANE STREET GROUP, LLC | $547.220 | 34.438 | 0,12% | Aktien |
| RHUMBLINE ADVISERS | $503.131 | 31.664 | 0,11% | Aktien |
| BARCLAYS PLC | $492.765 | 31.011 | 0,11% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $486.536 | 30.619 | 0,10% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Accelmed Partners II LP, Accelmed Partners II GP, L.P., Accelmed Partners II, LLC, Uri Geiger ×2 Einreichungen | 23. November 2022 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 17 Insider · 6 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Joel Becker | CHIEF EXECUTIVE OFFICER | 3. September 2026 F | 138.000 | 0 | 0 | $0 |
| Michael Favet | Chief Executive Officer | 21. Februar 2023 A | 407.080 | 0 | 0 | $0 |
| Patrick F. Williams | Chief Financial Officer | 20. September 2026 F | 67.508 | 0 | 0 | $0 |
| Rebecca Kuhn | CHIEF FINANCIAL OFFICER | 3. Juni 2025 F | 131.613 | 0 | 0 | $0 |
| Martha Morrell | CHIEF MEDICAL OFFICER | 24. September 2026 F | 51.357 | 0 | 1 | $-399.250 |
| Irina Ridley | Chief Legal Officer/Secretary | 20. Februar 2023 A | 141.139 | 0 | 0 | $0 |
| Rakhi Kumar | Direktor | 19. Juni 2026 A | 23.039 | 0 | 0 | $0 |
| Uri Geiger | Direktor | 19. Juni 2026 A | 18.537 | 0 | 0 | $0 |
| Frank M Fischer | Direktor | 19. Juni 2026 A | 599.534 | 0 | 0 | $0 |
| Renee Ryan | Direktor | 5. Juni 2026 A | 2.890 | 0 | 0 | $0 |
| Lisa Andrade | Direktor | 5. Juni 2026 A | 2.890 | 0 | 0 | $0 |
| Scott R Huennekens | Direktor | 5. Juni 2026 A | 2.890 | 0 | 0 | $0 |
| Joseph Lacob | Direktor | 20. März 2026 A | 14.754 | 0 | 0 | $0 |
| Greg Shaw Garfield | Direktor | 13. Juni 2022 A | 5.614.384 | 0 | 0 | $0 |
| Evan Norton | Direktor | 21. April 2021 A | 4.042.657 | 0 | 0 | $0 |
| KCK LTD. | 10%-Eigentümer | 20. Februar 2025 S | 0 | 0 | 0 | $0 |
| Accelmed Partners II L.P. | 10%-Eigentümer | 22. November 2022 P | 4.432.948 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 11 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,38% | 2.057 SH | 11. September 2026 | Täglich |
| IWC · iShares Trust | 0,09% | 89.476 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 248.901 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 28.462 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 676.027 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 12.674 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 152.437 SH | 19. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 11.385 SH | 3. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 290.278 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 908.479 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.828 SH | 19. August 2026 | Täglich |
NPCE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 15 Analysten
KAUF
Median-Ziel
$20.00
+57,5%
4 26,7%
Starker Kauf
10 66,7%
Kauf
1 6,7%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
10 Analysten · 2026-09-27Mittelwert-Ziel $20.00 +57,5%
← Unter allen Zielen
Aktueller Preis $12.70
Tief$18.00
Mittelwert$20.00
Hoch$22.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| SENS | $228M | -3.3 | 56.9% | -196.0% | -88.7% | 44.7% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| SI | $295M | -3.1 | 49.6% | -85.3% | -129.1% | 76.5% |
| CARL | $329M | -5.8 | 85.9% | -58.7% | -375.2% | 75.3% |
| OFIX | $604M | -6.5 | 2.9% | -11.2% | -20.3% | 68.8% |
| OBIO | $237M | -3.7 | 1169.2% | -157.4% | -195.7% | · |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 11, 2026